A subsidiary of Sinopep Biotech (stock code 688076) focusing on difficult oligonucleotides, small molecules, and peptide manufacturing, providing services from preclinical research to commercial manufacturing.
Relying on the company's 13 years of successful experience in process development services for small molecules, to peptides and oligonucleotide manufacturing from preclinical development to commercialization.
Utilizing Norteno and oligonucleotide technology platform we can provide customers with GMP production services from preclinical sample preparation to oligonucleotide APIs and preparations that meet domestic and foreign regulatory requirements.
Our process, analysis, formulation and regulatory teams provides customers with a fast, efficient, professional and flexible integrated solution for the entire oligonucleotide development process
The Apextide's oligonucleotide & peptide platforms are equipped with the most advanced international CYTIVA equipment to provide a "one-stop" manufacturing service from laboratory research and development, process development to clinical stage scale-up production to commercialization, laboratory scale (gram level), pilot scale to commercial production scale (100 grams to kilogram level).
Utilizing QHPLC/UPLC, LC-MS, LC-MS/MS, IC, GC, GC-MS, ICP-MS and other analytical facilities, which provide guarantee for oligonucleotide, peptide and small molecule structure characterization, analytical method development and verification, GMP production control and final product release testing, & stability research.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Complex Scientific Challenges.
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.apextide.com
- Keywords
- oligonucleotides, CDMO, peptides, small molecules, Custom Synthesis, GMP, Active Pharmaceutical Ingredients (APIs).
- Competitors
- 株式会社アクセラレート・バイオ, TriLink BioTechnologies, part of Maravai LifeSciences, Keshav Biochem Private Limited, Apextide, Deutsches Netzwerk gegen Antimikrobielle Resistenzen (DNAMR), Rienden Biotechnology Co., Ltd, Bachem, Chiral Chems, ibaco-services, Sinopep-Allsino Biopharmaceutical Co., Ltd..
Apextide Co., Ltd Questions
Apextide Co., Ltd's website is http://www.apextide.com
Apextide Co., Ltd's LinkedIn profile is https://www.linkedin.com/company/apextide-co-ltd
Apextide Co., Ltd has
4 employees.
View email and phone details for 4
employees at Apextide Co., Ltd.
Apextide Co., Ltd's industry is
Pharmaceutical Manufacturing
Apextide Co., Ltd's top competitors are
株式会社アクセラレート・バイオ,
Trilink Biotechnologies, Part Of Maravai Lifesciences,
Keshav Biochem Private Limited,
Apextide,
Deutsches Netzwerk Gegen Antimikrobielle Resistenzen (Dnamr),
Rienden Biotechnology Co., Ltd,
Bachem,
Chiral Chems,
Ibaco-Services,
Sinopep-Allsino Biopharmaceutical Co., Ltd..
Apextide Co., Ltd's categories are Pharmaceutical Manufacturing
Apextide Co., Ltd's founding year is 2022
